Schuppan D, Afdhal NH. Liver Cirrhosis. Lancet 2008;371(9615):838–851
Article CAS PubMed PubMed Central Google Scholar
Altekruse SF, Devesa SS, Dickie LA, McGlynn KA, Kleiner DE. Histological classification of liver and intrahepatic bile duct cancers in SEER registries. J Registry Manag 2011;38:201–205
PubMed PubMed Central Google Scholar
EASL–EORTC Clinical Practice Guideline Management of hepatocellular carcinoma. J Hepatol 2012;56:908–943
Paul SB, Chalamalasetty B, Vishnubatla S. Clinical profile, etiology and therapeutic outcome in 324 hepatocellular cancer in India. Oncology 2009;77:162–171
Thomas London W, Petrick JL, McGlynn KA. Liver cancer. In Thun M, Linet MS, Cerhan JR, Haiman CA, Schottenfeld D, editors., Cancer epidemiology and prevention. 4th ed. Oxford University Press; 2018. 635–660
Marengo A, Rosso C, Bugianesi E. Liver cancer: connections with obesity, fatty liver, and cirrhosis. Annu Rev Med 2016;67:103–117
Article CAS PubMed Google Scholar
Sulkowski MS, Gardiner DF, Rodriguez-Torres M, Reddy KR, Hassanein T, Jacobson I, et al. Daclatasvir plus sofosbuvir for previously treated or untreated chronic HCV infection. N Engl J Med 2014;370:211–221
Article CAS PubMed Google Scholar
Younossi Z, Stepanova M, Ong JP, Jacobson IM, Bugianesi E, Duseja A, et al. Nonalcoholic steatohepatitis is the fastest growing cause of hepatocellular carcinoma in liver transplant candidates. Clin Gastroenterol Hepatol 2019;17:748–755
Marrero JA, Kulik LM, Sirlin CB, Zhu AX, Finn RS, Abecassis MM, et al. Diagnosis, staging, and management of hepatocellular carcinoma: 2018 practice guidance by the american association for the study of liver diseases. Hepatology 2018;68:723–750
Bush K, Kivlahan DR, McDonell MB, Fihn SD, Bradley KA. The AUDIT alcohol consumption questions (AUDIT-C): an effective brief screening test for problem drinking. Ambulatory Care Quality Improvement Project (ACQUIP). Alcohol Use Disorders Identification Test. Arch Intern Med 1998;158(16):1789–1795. https://doi.org/10.1001/archinte.158.16.1789
Article CAS PubMed Google Scholar
Kumar R, Saraswat MK, Sharma BC, Sakhuja P, Sarin SK. Characteristics of hepatocellular carcinoma in India: a retrospective analysis of 191 cases. QJM 2008;101:479–485
Article CAS PubMed Google Scholar
Sherman M. Hepatocellular carcinoma: epidemiology, surveillance, and diagnosis. Semin Liver Dis 2010;30:3–16
Article CAS PubMed Google Scholar
Zhu RX, Seto WK, Lai CL, Yuen MF. Epidemiology of hepatocellular carcinoma in the Asia-Pacific Region. Gut Liver 2016;10:332–339
Article PubMed PubMed Central Google Scholar
Tham J, Goh TL, Barclay S, Priest M, Forrest E, Fraser A, et al. P221 Non-cirrhotic vs. Cirrhotic HCC: comparison between patient characteristics, aetiology and outcomes. Gut 2021;70:157–158
Castán A, Navarro Y, Sarría L, Larrosa R, Serradilla M, Serrablo A. Radiological diagnosis of hepatocellular carcinoma in non-cirrhotic patients. Hepatoma Res 2017;3:1
Trevisani F, Frigerio M, Santi V, Grignaschi A, Bernardi M. Hepatocellular carcinoma in non-cirrhotic liver: a reappraisal. Dig Liver Dis 2010;42:341–347
Kumar M, Kumar R, Hissar SS, Saraswat MK, Sharma BC, Sakhuja P, et al. Risk factors analysis for hepatocellular carcinoma in patients with and without cirrhosis: a case-control study of 213 hepatocellular carcinoma patients from India. J Gastroenterol Hepatol 2007;22:1104–1111
Sarin SK, Thakur V, Guptan RC, Saigal S, Malhotra V, Thyagarajan SP, et al. Profile of hepatocellular carcinoma in India: an insight into the possible etiologic associations. J Gastroenterol Hepatol 2001;16:666–673
Article CAS PubMed Google Scholar
Sanyal AJ, Yoon SK, Lencioni R. The etiology of hepatocellular carcinoma and consequences for treatment. Oncologist 2010;15(Suppl 4):14–22
Chayanupatkul M, Omino R, Mittal S, Kramer JR, Richardson P, El-Serag HB, et al. 12 the risk factors of hepatocellular carcinoma (HCC) in non-cirrhotic chronic hepatitis B patients in United States Veterans. Gastroenterology 2016;150:S4
el-Refaie A, Savage K, Bhattacharya S, Khakoo S, Harrison TJ, el-Batanony M, et al. HCV-associated hepatocellular carcinoma without cirrhosis. J Hepatol 1996;24:277–285
Article CAS PubMed Google Scholar
Nash KL, Woodall T, Brown AS, Davies SE, Alexander GJ. Hepatocellular carcinoma in patients with chronic hepatitis C virus infection without cirrhosis. World J Gastroenterol 2010;16:4061–4065
Article PubMed PubMed Central Google Scholar
Alotaibi AS, Alghamdi W, Marotta P, Qumosani K. A266 hepatocellular carcinoma prevalence in non-cirrhotic hepatitis C patients. J Can Assoc Gastroenterol 2018;1:383–384
Article PubMed Central Google Scholar
Perumpail RB, Liu A, Wong RJ, Ahmed A, Harrison SA. Pathogenesis of hepatocarcinogenesis in non-cirrhotic nonalcoholic fatty liver disease: potential mechanistic pathways. World J Hepatol 2015;7:2384–2388
Article PubMed PubMed Central Google Scholar
Piñero F, Pages J, Marciano S, Fernández N, Silva J, Anders M, et al. Fatty liver disease, an emerging etiology of hepatocellular carcinoma in Argentina. World J Hepatol 2018;10:41–50
Article PubMed PubMed Central Google Scholar
Alexander J, Torbenson M, Wu TT, Yeh MM. Non-alcoholic fatty liver disease contributes to hepatocarcinogenesis in non-cirrhotic liver: a clinical and pathological study. J Gastroenterol Hepatol 2013;28:848–854
Margini C, Dufour JF. The story of HCC in NAFLD: from epidemiology, across pathogenesis, to prevention and treatment. Liver Int 2016;36:317–324
Article CAS PubMed Google Scholar
Balakrishnan M, El-Serag HB. Editorial: NAFLD-related hepatocellular carcinoma—increasing or not? With or without cirrhosis? Aliment Pharmacol Ther 2018;47:437–438
Article CAS PubMed PubMed Central Google Scholar
Mancina RM, Dongiovanni P, Petta S, Pingitore P, Meroni M, Rametta R, et al. The MBOAT7-TMC4 variant rs641738 increases risk of nonalcoholic fatty liver disease in individuals of European descent. Gastroenterology 2016;150(5):1219–1230
Article CAS PubMed Google Scholar
Donati B, Dongiovanni P, Romeo S, Meroni M, McCain M, Miele L, et al. MBOAT7 rs641738 variant and hepatocellular carcinoma in non-cirrhotic individuals. Sci Rep 2017;7(1):4492
Article PubMed PubMed Central Google Scholar
Papatheodoridi AM, Chrysavgis L, Koutsilieris M, Chatzigeorgiou A. The role of senescence in the development of nonalcoholic fatty liver disease and progression to nonalcoholic steatohepatitis. Hepatology 2020;71:363–374
Article CAS PubMed Google Scholar
Bhatti HBA, Sheikh EAA, Mahmud SU, Zeeshan S, Khan NY, Zia HH, et al. Clinical profile and treatment of hepatocellular carcinoma: a single-center experience. South Asian J Cancer 2021;10(2):76–80
Article PubMed PubMed Central Google Scholar
Saini N, Bhagat A, Sharma S, Duseja A, Chawla Y. Evaluation of clinical and biochemical parameters in hepatocellular carcinoma: experience from an Indian center. Clin Chim Acta 2006;371:183–186
Article CAS PubMed Google Scholar
Sood A, Midha V, Goyal O, Goyal P, Sood N, Sharma SK. Profile of hepatocellular carcinoma in a tertiary care hospital in Punjab in northern India. Indian J Gastroenterol 2014;33:35–40
Pal S, Ramachandran J, Kurien RT, Eapen A, Ramakrishna B, Keshava SN, et al. Hepatocellular carcinoma continues to be diagnosed in the advanced stage: profile of hepatocellular carcinoma in a tertiary care hospital in South India. Trop Doct 2013;43:25–26
David D, Raghavendran A, Goel A, Bharath Kumar C, Kodiatte TA, Burad D, et al. Risk factors for non-alcoholic fatty liver disease are common in patients with non-B non-C hepatocellular carcinoma in India. Indian J Gastroenterol 2017;36:373–379
Musunuri B, Shetty S, Bhat G, Udupa K, Pai A. Profile of patients with hepatocellular carcinoma: an experience from a tertiary care center in India. Indian J Gastroenterol 2022;41(2):127–134. https://doi.org/10.1007/s12664-021-01209-0
留言 (0)